Low Volume High Intensity Interval Training in Operated Lung Cancer Patients

Sponsor
Hacettepe University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05837429
Collaborator
Ankara University (Other)
40
1
2
24
1.7

Study Details

Study Description

Brief Summary

Patients included in the study will be randomly divided into 2 groups using appropriate randomization programs. All patients will be given exercise training individually for 24 sessions using a bicycle ergometer under the supervision of a physiotherapist.Patients in the first group will be given exercise training on a bicycle ergometer for 5 minutes warm-up phase at 40% of maximal oxygen consumption (VO2max), 20 minutes exercise phase at 60% of VO2max and 5 minutes cool down phase at 40% of VO2max for a total of 30 minutes. Patients in the second group will be given a warm-up phase for 3 minutes at 50% VO2max, 1 minute at 80-100% VO2max and 1 minute at 50% VO2max in 10 cycles, and finally a cool-down phase for 3 minutes at 50% VO2max. In total, 25 minutes of low-volume high-intensity intermittent exercise training will be given on a bicycle ergometer.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Low Volume High Intensity Exercise Training
  • Behavioral: Aerobic Exercise Training
N/A

Detailed Description

The study will include patients diagnosed with non-small cell lung cancer who have completed adjuvant treatments such as chemotherapy and radiotherapy at least 6 months ago, stage 3A or earlier,clinically stable remission (no recurrence or active cancer), and have been followed by Ankara University Medical Oncology Department. Patients who have undergone pneumonectomy surgery, patients with advanced COPD and cardiac disease, patients with orthopedic or neurological problems who cannot adapt to exercise will be excluded. Patients included in the study will be randomly divided into 2 groups using appropriate randomization programs. All patients will be given exercise training individually for 24 sessions using a bicycle ergometer under the supervision of a physiotherapist. To determine the intensity of exercise training, all patients will undergo Cardiopulmonary Exercise Test (CPET) on a bicycle ergometer under the supervision of a physiotherapist and a physician before the training sessions. During CPET, maximal oxygen capacity, diffusion capacity, heart rate variability as a marker of autonomic function and heart rate recovery will be measured. Patients in the first group will be given exercise training on a bicycle ergometer for 5 minutes warm-up phase at 40% of maximal oxygen consumption (VO2max), 20 minutes exercise phase at 60% of VO2max and 5 minutes cool down phase at 40% of VO2max for a total of 30 minutes. Patients in the second group will be given a warm-up phase for 3 minutes at 50% VO2max, 1 minute at 80-100% VO2max and 1 minute at 50% VO2max in 10 cycles, and finally a cool-down phase for 3 minutes at 50% VO2max. In total, 25 minutes of low-volume high-intensity intermittent exercise training will be given on a bicycle ergometer. After the exercise training, CPET will be performed again in the presence of a physician and physiotherapist to evaluate the effectiveness of the exercise. Blood samples of all groups will be taken by the physician before and after training to obtain information about the change in oxidative stress (total oxidant status, total antioxidant status) and myokine (irisin hormone) biomarkers between the two exercise modalities. Knee extensors and hand grip strength will be evaluated with a dynamometer as part of the peripheral muscle strength assessment of all groups before and after the training. EORTC QLQ-C30 quality of life questionnaire and London Chest Activities of Daily Living Scale will be used to evaluate the effect of exercise training on quality of life and activities of daily living before and after training.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of the Effects of Continuous Aerobic Exercise Training and Low Volume High Intensity Interval Training on Cardiopulmonary Exercise Capacity, Autonomic Function and Oxidative Stress in Operated Lung Cancer Patients
Actual Study Start Date :
Apr 6, 2023
Anticipated Primary Completion Date :
Apr 6, 2025
Anticipated Study Completion Date :
Apr 6, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Low Volume High Intensity Exercise Training

Patients in the intervention group will be given a warm-up phase for 3 minutes at 50% VO2max, 1 minute at 80-100% VO2max and 1 minute at 50% VO2max in 10 cycles, and finally a cool-down phase for 3 minutes at 50% VO2max.

Behavioral: Low Volume High Intensity Exercise Training
Patients in the intervention group will be given a warm-up phase for 3 minutes at 50% VO2max, 1 minute at 80-100% VO2max and 1 minute at 50% VO2max in 10 cycles, and finally a cool-down phase for 3 minutes at 50% VO2max.

Active Comparator: Aerobic Exercise

Patients in the control group will be given exercise training on a bicycle ergometer for 5 minutes warm-up phase at 40% of maximal oxygen consumption (VO2max), 20 minutes exercise phase at 60% of VO2max and 5 minutes cool down phase at 40% of VO2max for a total of 30 minutes.

Behavioral: Aerobic Exercise Training
Patients in the control group will be given exercise training on a bicycle ergometer for 5 minutes warm-up phase at 40% of maximal oxygen consumption (VO2max), 20 minutes exercise phase at 60% of VO2max and 5 minutes cool down phase at 40% of VO2max for a total of 30 minutes.

Outcome Measures

Primary Outcome Measures

  1. Maximal oxygen consumption [24 months]

    To be measured during cardiopulmonary exercise testing

  2. Heart Rate Variability [24 months]

    To be measured during cardiopulmonary exercise testing

  3. Oxidative Stress [24 months]

    Lipid peroxidation marker from serum for determination of oxidative damage melondialdehyde (MDA), total oxidant status (TOS), total antioxidant status (TAS) parameters will be evaluated.

  4. Myokine [24 months]

    Irisin levels in serum, enzyme-linked immunosorbent assay (Enzyme-Linked Immuno Sorbent Assay-ELISA) method using a commercial kit.

Secondary Outcome Measures

  1. Change in quality of life [24 months]

    The European Organisation for Research and Treatment of Cancer (EORTC) quality of life questionnaire QLQ-C30 will be used for quality of life assessment. Higher scores reflect better function, whereas lower scores suggest impairment.

  2. Peripheral Muscle Strength [24 months]

    The strength of the knee extensors will be measure using a digital dynamometer (Lafayette, Lafayette Instrument, Lafayette, IN, USA). The test will repeat 3 times on the dominant side and recorded in kilograms (kg). A Jamar hand dynamometer (Fabrication Enterprises, New York, USA) will be use to measure the handgrip strength. The measurement will repeat 3 times on the dominant side and recorded in kg.

  3. Activity of Daily Living [24 months]

    London Chest Activity of Daily Living Scale will be used for activity of daily living assessment. Low scores represent high activity.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Diagnosed with Non-Small Cell Lung Cancer

  • Stage 3A and earlier

  • Operated and at least 6 months have expired since the surgery

  • Having completed adjuvant treatments such as chemotherapy and radiotherapy and at least 6 months have expired

  • Being clinically stable and in remission

  • Not having new recurrence and active cancer

Exclusion Criteria:
  • Pneumonectomy surgery

  • Presence of symptoms, signs and diagnoses indicating the presence of lung and cardiac disease such as advanced COPD

  • Having any orthopedic or neurological problem that may prevent exercise

  • Presence of recurrence or active cancer

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ankara University Ankara Sıhhiye Turkey

Sponsors and Collaborators

  • Hacettepe University
  • Ankara University

Investigators

  • Principal Investigator: Hamide Sahin-Yildiz, Msc,PT, Ankara University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hamide Sahin-Yildiz, Principal Investigator, PT, Msc, Ankara University
ClinicalTrials.gov Identifier:
NCT05837429
Other Study ID Numbers:
  • 04-194-22
First Posted:
May 1, 2023
Last Update Posted:
May 1, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hamide Sahin-Yildiz, Principal Investigator, PT, Msc, Ankara University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 1, 2023